Hemofiltration for Contrast-Induced Nephropathy

The recruitment status of this study is unknown because the information has not been verified recently.
Verified September 2005 by Nara Medical University.
Recruitment status was  Recruiting
Information provided by:
Nara Medical University
ClinicalTrials.gov Identifier:
First received: September 7, 2005
Last updated: NA
Last verified: September 2005
History: No changes posted
Contrast-induced acute renal failure can be prevented with hemofiltration which is performed during cardiac catheterization

Condition Intervention
Chronic Kidney Disease
Cardiac Catheterization
Procedure: hemofiltration

Study Type: Interventional
Study Design: Allocation: Randomized
Endpoint Classification: Efficacy Study
Intervention Model: Parallel Assignment
Masking: Open Label
Primary Purpose: Prevention
Official Title: Prevention of Contrast-Induced Nephropathy by Real-Time Hemofiltration

Resource links provided by NLM:

Further study details as provided by Nara Medical University:

Primary Outcome Measures:
  • Prevention of contrast-induced acute renal failure, Elevation of serum creatinine

Secondary Outcome Measures:
  • Need for hemodialysis

Estimated Enrollment: 100

Ages Eligible for Study:   20 Years to 90 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • Patients with serum creatinine>2.0mg/dl and/or GFR<50ml/min

Exclusion Criteria:

  • Emergent cardiac catheterization
  • Patients on chronic dialysis
  • Patients with HYHA>III heart failure
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00158080

Contact: Koji Harada, MD +81-744-22-3051 ext 3411 kzharada@naramed-u.ac.jp

First Dept of InternalMedicine, Nara Medical University Recruiting
Kashihara, Nara, Japan, 634-8522
Contact: Koji Harada, MD    +81-744-22-3051 ext 3411    kzharada@naramed-u.ac.jp   
Sponsors and Collaborators
Nara Medical University
Study Director: Yoshihiko Saito, MD, PhD Nara Medical University
  More Information

ClinicalTrials.gov Identifier: NCT00158080     History of Changes
Other Study ID Numbers: K0001 
Study First Received: September 7, 2005
Last Updated: September 7, 2005
Health Authority: Japan: Ministry of Health, Labor and Welfare

Additional relevant MeSH terms:
Kidney Diseases
Renal Insufficiency, Chronic
Renal Insufficiency
Urologic Diseases

ClinicalTrials.gov processed this record on February 11, 2016